STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Lyell Immunopharma, Inc.
LYEL
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$0.00
-55.0%
Net Income/Share
$-26.23
-40.3%
Operating CF/Share
$-12.42
+4.8%
Free CF/Share
$-12.46
+6.0%
Cash/Share
$28.34
-34.9%
Book Value/Share
$29.28
-43.9%
Tangible Book/Share
$29.28
-43.9%
Equity/Share
$29.28
-43.9%
Interest Debt/Share
$4.51
-10.4%
Valuation
Market Cap
$167.35M
-65.6%
Enterprise Value
$120.72M
-70.2%
P/E Ratio
-0.49
+76.5%
P/S Ratio
2,743.40
-26.8%
P/OCF Ratio
-1.03
+65.4%
P/FCF Ratio
-1.03
+64.9%
P/B Ratio
0.44
-41.2%
P/TB Ratio
0.44
-41.2%
EV/Sales
1,978.99
-36.4%
EV/EBITDA
-0.60
+66.3%
Profitability
Earnings Yield
-204.96%
-325.3%
FCF Yield
-97.32%
-184.8%
ROE
-89.60%
-150.1%
ROIC
-80.61%
-135.6%
Return on Tangible Assets
-69.88%
-123.4%
Capital Allocation
CapEx/OCF
-0.29%
+82.6%
CapEx/Revenue
760.66%
-63.2%
CapEx/Depreciation
0.02
-82.2%
SBC/Revenue
54334.43%
+50.0%
Balance Sheet
Debt/Equity
0.15
+59.7%
Debt/Assets
0.12
+42.6%
Net Debt/EBITDA
0.23
-36.1%
Current Ratio
7.06
-56.1%
Interest Coverage
0.00x
Income Quality
0.47
-32.1%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$20.08
-44.2%